Quantum BioPharma Ltd. (CSE:QNTM)
4.990
+0.490 (10.89%)
At close: Apr 10, 2026
Quantum BioPharma Market Cap
Quantum BioPharma has a market cap or net worth of CAD 29.09 million as of April 10, 2026. Its market cap has increased by 82.98% in one year.
Market Cap
29.09M
Enterprise Value
25.92M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.99
Market Cap Chart
Since May 29, 2018, Quantum BioPharma's market cap has decreased from 158.35M to 29.09M, a decrease of -81.63%. That is a compound annual growth rate of -19.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 29.09M | -27.76% |
| Dec 31, 2025 | 40.26M | 301.84% |
| Dec 31, 2024 | 10.02M | -78.79% |
| Dec 29, 2023 | 47.25M | 18.00% |
| Dec 30, 2022 | 40.04M | -24.98% |
| Dec 31, 2021 | 53.38M | 39.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| May 29, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 50.89M |
| BriaCell Therapeutics | 44.30M |
| MedMira | 42.10M |
| Defence Therapeutics | 41.57M |
| Devonian Health Group | 33.37M |
| Resverlogix | 33.20M |
| Telescope Innovations | 33.13M |
| Microbix Biosystems | 31.06M |